1 / 15

Oxidative DNA Damage is Reduced by a Daily Micronutrient Supplement in HD Patients

Oxidative DNA Damage is Reduced by a Daily Micronutrient Supplement in HD Patients. Dr Mary Hannon-Fletcher. 2nd International Vitamin Conference 23 rd May 2012 Copenhagen. Background.

zacharyperez
Télécharger la présentation

Oxidative DNA Damage is Reduced by a Daily Micronutrient Supplement in HD Patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Oxidative DNA Damage is Reduced by a Daily Micronutrient Supplement in HD Patients Dr Mary Hannon-Fletcher 2nd International Vitamin Conference 23rd May 2012 Copenhagen

  2. Background • End stage renal disease is associated with an increase in oxidative stress, cardiovascular disease and cancer • Haemodialysis induces repetitive bouts of oxidative stress • Resulting in increased levels of reactive oxygen species • Leading to increased levels of oxidative DNA damage and thus genomic instability • May impact on the elevated levels of cancer reported in HD patients

  3. Diet in HD Patients • Malnutrition is prevalent in 40-50% • Very restricted diets resulting in regulation of certain nutrients such as: • sodium, potassium, phosphate, protein & fluids • Reduction or exclusion of certain foods increases the risk of inadequate intakes • Under-nutrition exacerbates oxidative stress • Together with the increased losses of essential minerals and water-soluble vitamins via HD • Many studies have reported HD patients deficient in several important vitamins

  4. Background • Data in our lab showed HD patients had significantly elevated levels of DNA damage compared to age and gender matched controls Aim • Using a novel micronutrient supplement containing physiological levels of folate, B, C and E -vitamins, and micronutrients • To determine if a 3 month placebo controlled intervention would effect levels of DNA damage

  5. Study Design Thirty Nine Participants Recruited Baseline Clinical History & Blood Sample Treatment n =18 Placebo n=19 Randomised to treatment 3 month intervention n=16 n = 15 Post Intervention Clinical History & Blood Sample

  6. Participants and Methods • Ethical permission was obtained from ORECNI and Governance was obtained from the WHSCT • DNA Damage was measured using the Comet assay (% tail DNA) • Oxidative specific DNA damage measured using bacterial enzymes: • Endonuclease III (Endo III) • Formamidepyrimidine DNA glycosilase (FPG) • Supplements were provided monthly in a bottle by the pharmacist • Volunteers were withdrawn if less than 90% of the supplements were taken

  7. The Comet Assay

  8. Assessment of DNA Damage The Comet assay is a Single Cell Microelectrophoretic method for the quantitative measurement of DNA damage and alkali labile sites. Damaged cells have the appearance of a comet with a tail owing to extension of the DNA towards the anode (Mc Kelvey Martin et al., Mut Res 288 (1993) 47-63).

  9. Table 1: Volunteer Baseline Characteristics Values are presented as mean ± SD

  10. Figure 2 Changes in DNA Damage in Treatment Group Post Intervention % Tail DNA *** *** *** Values are mean ± SD *p>0.001

  11. Table 2: DNA Damage in Placebo Group . Values are mean ±SD **p>0.001;p>0.05 compared to baseline

  12. Summary • A significant reduction in Alkaline, EndoIII and FPG DNA damage post intervention in the treatment group • Placebo DNA damage levels significantly increased from baseline

  13. Conclusion • These data show for the first time that physiological levels of a novel supplement reduces levels of DNA damage • This novel treatment had a protective effect on the patient blood levels of DNA damage • In addition, the most significant reduction in DNA damage levels was observed in those patients with higher baseline levels • Additional research is urgently required

  14. Acknowledgements • Supported by grant from WHCST • Amgen / Irish Nephrological Society Research Award • Thanks to the research group: • Dr Peter Garrett • Ms Twyla Moffitt

  15. Supplement Prescription: Patent Protected

More Related